MYD88 and glioblastoma: Forest plots indicated that CD36 had significant survival relevance in KIRC and STAD (Figure 9A), while MYD88 was related to survival in ACC, BLCA, GBM, KICH, LGG, MESO, PAAD and READ (Figure 9B).